Paragangliomas: Clinical overview

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 21-29

  Young Jr , William F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Catecholamines; Metanephrines; Paraganglioma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; CATECHOLAMINE; FLUORODEOXYGLUCOSE F 18; METADRENALIN;

ALPHA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC RECEPTOR BLOCKING; BLADDER; CARNEY COMPLEX; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CHROMAFFIN SYSTEM; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; FLUOROMETRY; GENE MUTATION; GENETIC COUNSELING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFERIOR MESENTERIC ARTERY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; POSITRON EMISSION TOMOGRAPHY; SYMPTOM; VON HIPPEL LINDAU DISEASE;

EID: 33845506053     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.002     Document Type: Conference Paper

References (21)

1. LACK, E.E. 2000. Tumours of adrenal and extra-adrenal paraganglia. In Histological Typing of Endocrine Tumors, 2nd. ed. Solae, G. Kloppel & L.H. Sobin, Eds.: 38-48. Springer. Berlin.
2. FRIES, J.G. & J.A. CHAMBERLIN. 1968. Extra-adrenal pheochromocytoma: literature review and report of a cervical pheochromocytoma. Surgery 63: 268-279.
3. LLOYD, R.V., A.S. TISCHER, N. KIMURA, et al. 2004. Adrenal tumors: introduction. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. R. A. DeLellis, R.V. Lloyd, P.U. Heitz & C. Eng, Eds.: 136-138. IARC Press. Lyon, France.
4. WHALEN, R.K., A.F. ALTHAUSEN & G.H. DANIELS. 1992. Extra-adrenal pheochromocytoma. J. Urol. 147: 1-10.
5. BEARD, C.M., S.G. SHEPS, L.T. KURLAND, et al. 1983. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 58: 802-804.
6. ERICKSON, D., Y.C. KUDVA, M.J. EBERSOLD, et al. 2001. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J. Clin. Endocrinol. Metab. 86: 5210-5216.
7. LENDERS, J.W., K. PACAK, M.M. WALTHER, et al. 2002. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 287: 1427-1434.
8. KUDVA, Y.C., A.M. SAWKA & W.F. YOUNG Jr. 2003. Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo clinic experience. J. Clin. Endocrinol. Metab. 88: 4533-4539.
9. BRANTIGAN, C.O. & R.Y. KATASE. 1969. Clinical and pathologic features of paragangliomas of the organ of Zuckerkandl. Surgery 65: 898-905.
10. O'RIORDAIN, D.S., W.F. YOUNGJr & C.S. GRANT, et al. 1996. Clinical spectrum and outcome of functional extra-adrenal paraganglioma. World J. Surg. 20: 916-921.
11. ILIAS, I., J. YU, J.A. CARRASQUILLO, et al. 2003. Superiority of 6-[(18)F]-fluorodopamine positron emission tomography versus [(131)I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J. Clin. Endocrinol. Metab. 88: 4083-4087.
12. CARNEY, J.A. 1999. Gastric stromal sarcoma, pulmonary chondroma, and extraadrenal paraganglioma (Carney triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin. Proc. 74: 543-552.
13. BAYSAL, B.E., R.E. FERRELL, J.E. WILLETT-BROZICK, et al. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851.
14. BENN, D.E., A.-P. GIMENEZ-ROQUEPLO, J.R. REILLY, et al. 2006. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J. Clin. Endocrinol. Metab. 91: In press.
15. SCHIAVI, F., C.C. BOEDEKER, B. BAUSCH, et al. 2005. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294: 2057-2063.
16. NEUMANN, H.P., C. PAWLU, M. PECZKOWSKA, et al. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292: 943-951.
17. YOUNG, A.L., B.E. BAYSAL, A. DEB & W.F. YOUNGJr. 2002. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J. Clin. Endocrinol. Metab. 87: 4101-4105.
18. GIMENEZ-ROQUEPLO, A.P., J. FAVIER, P. RUSTIN, et al. 2003. Mutations in SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 63: 5615-5621.
19. BAYLEY, J.P., P. DEVILEE & P.E. TASCHNER. 2005. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med. Genet. 6: 39.
20. YOUNG, W.F. Jr. & A.L. ABBOUD. 2006. Paraganglioma: all in the family. J. Clin. Endocrinol. Metab. 91: 790-792.
21. KINNEY, M.A., M.E. WARNER, J.A. VANHEERDEN, et al. 2000. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth. Analg. 91: 1118-1123.